Synthesis of 3-Aryloxazolidin-2-one Derivatives
FULL PAPERS
gave the mono- (yield: 196.6 mg, 54%) and bis-coupled (yield:
86.4 mg, 24%) products. Total yield: 78%.
Bis-Coupled Product (Table 2, entry 4)
1
Following the general procedure, 3-(4’-iodophenyl)-4-methyl-
5-phenyl-2-oxazolidinone (379 mg, 1 mmol), the oxazolidi-
none (161 mg, 1 mmol), CuI(19 mg, 10 mol %), ethylenedia-
mine (6 mg, 10 mol %), K3PO4 (424 mg, 2 mmol) and 3 mL of
dry dioxane at 808C for 24 h gave the bis-coupled product;
Mono-coupled product A: H NMR: d¼7.60 7.58 (d, J¼
8.79 Hz, 2H, Ar), 7.12 7.09 (d, J¼8.8 Hz, 2H, Ar), 4.47
4.25 (t, J¼8.2 Hz, 1H, -N-CH), 4.34 4.26 (m, 1H, O-CH2),
4.04 4.00 (dd, J¼5.0, 8.32 Hz, 1H, O-CH2), 1.59 1.54 (m,
2H, CH2), 1.40 1.34 (m, 1H, CH), 0.88 0.84 (m, 6H, 2CH3);
13C NMR: d¼155.03, 138.0, 136.6, 123.0, 67.39, 54.5, 40.8,
29.6, 24.6, 23.5; HR-MS: calcd. for Mþ: 345.0226; found:
345.0227.
1
yield: 383 mg (93%); mp 140 1428C; H NMR (CDCl3): d¼
7.51 7.20 (m, 9H, Ar), 5.7 (d, J¼7.7 Hz, O-CH-Ph), 4.68
4.59 (m, 1H, N-CH-CH3), 4.51 4.46 (m, 2H, O-CH2), 4.13
4.09 (m, 1H, N-CH-), 2.52 2.39 (m, 2H, CH2-S-), 1.97 (s, 3H,
-S-CH3), 1.81 1.75 (m, 2H, -S-CH2-CH2-), 0.76 (d, J¼6.4 Hz,
CH3); 13C NMR: d¼155.3, 154.8, 134.4, 133.9, 133.3, 128.5,
125.9, 122.28, 122.25, 78.1, 69.8, 56.7, 55.2, 34.1, 29.2, 15.6, 14.4.
Bis coupled product B: 1H NMR (CDCl3): d¼7.36 (m, 4H,
Ar), 4.50 4.41 (t, J¼8 Hz, 2H), 4.35 4.33 (m, 2H), 4.07
4.02 (dd, J¼5.3, 8.08 Hz, 2H), 1.64 1.53 (m, 4H), 1.36 1.0
(m, 2H), 0.89 0.85 (12H, 4CH3); 13C NMR: d¼155.5, 133.7,
122.2, 67.5, 54.9, 41.1, 24.7, 23.5, 21.6; HR-MS: calcd. for Mþ:
360.2049; found: 360.2045.
Bis-Coupled Product (Table 2, entry 5)
Bis-Coupled Product (Table 2, entry 1)
Following the general procedure, 3-(4’-iodophenyl)-4-methyl-
phenyl-2-oxazolidinone (379 mg, 1 mmol), the oxazolidinone
(177 mg, 1 mmol), CuI(19 mg, 10 mol %), ethylenediamine
(6 mg, 10 mol %), K3PO4 (424 mg, 2 mmol) and 3 mL of dry di-
oxane at 808C for 24 h gave the bis-coupled product; yield:
325 mg (76%); data same as for Table 1, entry 2B above.
Following the general procedure, 3-(4’-iodophenyl)-4-methyl-
5-phenyl-2-oxazolidinone (379 mg, 1 mmol), the respective ox-
azolidinone (177 mg, 1 mmol), CuI(19 mg, 10 mol %), ethyle-
nediamine (6 mg, 10 mol %), K3PO4 (424 mg, 2 mmol) and
3 mL of dry dioxane at808C for 24 hgave the bis-coupled prod-
uct; yield: 278 mg (65%); data same as for Table 1, entry 1B
above.
Bis-Coupled Product (Table 2, entry 6)
Following the general procedure, 3-(4’-iodophenyl)-4-methyl-
phenyl-2-oxazolidinone (379 mg, 1 mmol), oxazolidinone
(129 mg, 1 mmol), CuI(19 mg, 10 mol %), ethylenediamine
(6 mg, 10 mol %), K3PO4 (424 mg, 2 mmol) and 3 mL of dry di-
oxane at 808C for 24 h gave the bis-coupled product; yield:
Bis-Coupled Product (Table 2, entry 2)
Following the general procedure, 3-(4’-iodophenyl)-4-methyl-
5-phenyl 2-oxazolidinone (379 mg, 1 mmol), the oxazolidinone
(177 mg, 1 mmol), CuI(19 mg, 10 mol %), ethylenediamine
(6 mg, 10 mol %), K3PO4 (424 mg, 2 mmol) and 3 mL of dry di-
oxane at 808C for 24 h gave the bis-coupled product; yield:
282.4 mg (66%); mp 188 1908C; 1H NMR (CDCl3): d¼
7.51 7.41 (m, 3H, Ar), 7.3 7.29 (m, 6H, Ar), 7.2 7.1 (m,
3H, Ar), 7.06 7.03 (m, 2H, Ar), 5.75 (d, J¼7.7 Hz, CH-Ph),
4.71 4.60 (m, 2H, O-CH2), 4.31 (t, J¼8.5 Hz, N-CH), 4.14
1
254 mg (67%); mp 268 2708C; H NMR (CDCl3): d¼7.52
7.43 (m, 3H, Ar), 7.26 7.22 (m, 2H,Ar), 7.18 (m, 2H, Ar),
7.11 7.04 (m, 2H, Ar), 4.56 4.52 (dd, J¼4.2, 8.7 Hz, 1H,
-CH-CH2-Ph), 4.39 4.35 (m, 2H, O-CH2-), 4.31 4.25 (m,
1H, -CH-N-), 4.19 4.11 (m,2H, O-CH2-), 3.12 (dd, J¼3.5,
13.7 Hz, 1H, Ph-CH2- ), 2.7 (dd, J¼9.4, 13.7 Hz, 1H, C6H5-
CH-), 2.11 (m, -CH-), 0.88 0.80 (m, 6H, 2CH3);13C NMR:
¼
(dd, J 4.7, 8.7 Hz, 1H, N-CH), 3.0 (dd, J¼3.24, 13.7 Hz, 1H,
Ph-CH2), 2.75 (dd, J¼9.1, 13.7 Hz, 1H, Ph-CH2), 0.79 (t, J¼
6.4 Hz, 3H, CH3); 13C NMR: d¼155.0, 154.6, 134.7, 134.3,
133.7, 133.3, 128.9, 128.4, 127.0, 125.7, 122.1, 122.0, 77.9, 66.7,
65.7, 56.9, 37.5, 14.3; HR-MS: calcd. for Mþ: 428.1736; found:
428.1739.
¼
¼
d¼155.8 (C O), 154.7 (C O), 134.5, 133.8, 133.2, 128.8,
126.2, 123.5, 122.7, 78.4, 57.1, 56.2, 27.6, 14.7, 14.3; HR-MS:
calcd. for Mþ: 380.1736; found: 380.1740.
Bis-Coupled Product (Table 2, entry 7)
Bis-Coupled Product (Table 2, entry 3)
Following the general procedure, 3-(4’-iodophenyl)-4-methyl-
phenyl-2-oxazolidinone (379 mg, 1 mmol), the oxazolidinone
(143 mg, 1 mmol), CuI(19 mg, 10 mol %), ethylenediamine
(6 mg, 10 mol %), K3PO4 (424 mg, 2 mmol) and 3 mL of dry di-
oxane at 808C for 24 h gave the bis-coupled product; yield:
Following the general procedure, 3-(4’-iodophenyl)-4-methyl-
5-phenyl 2-oxazolidinone (379 mg, 1 mmol), the oxazolidinone
(129 mg, 1 mmol), CuI(19 mg, 10 mol %), ethylenediamine
(6 mg, 10 mol %), K3PO4 (424 mg, 2 mmol) and 3 mL of dry di-
oxane at 808C for 5 h gave the bis-coupled product; yield:
1
263 mg (67%); H NMR (CDCl3): d¼7.59 7.46 (m, 4H, Ar),
1
300 mg (79%); H NMR (CDCl3): d¼7.5 7.1 (m, 9H, Ar),
7.29 7.25 (m, 3H, Ar), 7.13 7.11 (m, 2H, Ar), 4.63 4.34 (m,
4H, OCH2), 4.23 4.16 (m, 2H, -N-CH), 3.19 (dd, J¼3.3 Hz,
13.6 Hz, 1H, Ph-CH2), 2.8 (dd, J¼13.7, 9.5 Hz, 1H, Ph-CH2),
5.72 (d, J¼7.7 Hz, 1H, O-CH-Ph), 4.6 4.58 (m, 1H, CH3-
CH-N), 4.37 4.30 (m, 2H, O-CH2-), 4.19 4.12 (m, 1H, N-
CH), 2.09 2.06 (m, 1H, CH), 0.85 (d, J¼7.10 Hz, 3H, CH3),
0.78 0.75 (m, 6H, 2CH3); 13C NMR: d¼155.83, 154.92,
134.59, 133.93, 133.67, 128.66, 126.03, 122.83, 122.38, 122.29,
121.68, 78.18, 62.40, 60.51, 56.96, 27.52, 17.7, 14.5, 14.2; HR-
MS: calcd. for Mþ: 380.1736; found: 380.1743.
1.6 1.2 (m, 3H, Ph-CH2-CH-), 0.98 0.86 (m, 6H, 2CH3);
13
¼
¼
C NMR: d¼155.46 (C O), 155.3 (C O), 135.2, 134.0, 133.8,
129.1, 129.0, 127.3, 122.5, 122.2, 121.8, 77.4, 70.6, 51.6, 44.6,
41.3, 38.0, 25.1, 22.9, 22.2; HR-MS: calcd. for Mþ: 394.1893;
found: 394.1890.
Adv. Synth. Catal. 2004, 346, 954 958
asc.wiley-vch.de
¹ 2004 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
957